Solabia Group, a global leader in biotechnology-driven active ingredients for health and beauty industries, has announced that it has entered into an agreement to acquire Mibelle Biochemistry, a renowned Swiss innovator specialised in the development and production of unique, high-performance active ingredients for the cosmetics, nutraceutical, and food industries, from Persán, a multinational and European market leader in the areas of home and personal care.
Founded in 1991 in Switzerland as part of the Mibelle Group, Mibelle Biochemistry offers a science-backed portfolio spanning skin beauty, healthy aging, hair care, and cognitive support, with distribution in more than 50 countries. The company is recognised globally for translating nature’s concepts into effective and innovative ingredients.
The acquisition of Mibelle Biochemistry strengthens Solabia’s leadership in natural and high-performance active ingredients by bringing together two science-driven organisations with highly complementary expertise in advanced biotechnology, plant-based science and sustainable innovation. Customers will benefit from a broader portfolio while continuing to rely on the known Swiss-made quality of Mibelle Biochemistry.
Jean-Baptiste Dellon, Chief Executive Officer of Solabia, said: “We are very excited to welcome Mibelle Biochemistry’s expert teams to Solabia. Mibelle Biochemistry is a company we have long admired for its scientific rigor, innovative spirit, and pioneering work. Together, we will accelerate innovation, expand our global reach, and deliver even stronger value to a larger customer base seeking differentiated, science-backed solutions for beauty and wellbeing.”
Cornelia Schürch, Head of Mibelle Biochemistry, commented: “Over more than three decades, Mibelle Biochemistry has built a global reputation for cutting-edge biotechnology and high-quality natural active ingredients. Joining Solabia marks an exciting next chapter for our team. We are gaining a strong, highly aligned partner who understands our markets and shares our passion for scientific excellence. This transaction will allow us to innovate faster, scale our technologies, and bring even more impactful ingredients to customers around the world.”
The transaction is expected to close in the coming months. Financial terms were not disclosed.
